TY - JOUR
T1 - Cervical chordomas
T2 - multicenter case series and meta-analysis
AU - Akinduro, Oluwaseun O.
AU - Garcia, Diogo P.
AU - Domingo, Ricardo A.
AU - Vivas-Buitrago, Tito
AU - Sousa-Pinto, Bernardo
AU - Bydon, Mohamad
AU - Clarke, Michelle J.
AU - Gokaslan, Ziya L.
AU - Kalani, Maziyar A.
AU - Abode-Iyamah, Kingsley
AU - Quiñones-Hinojosa, Alfredo
N1 - Funding Information:
AQH was supported by the Mayo Clinic Professorship, the Mayo Clinic Clinician Investigator award, the Florida Department of Health Cancer Research Chair Fund, as well as the National Institutes of Health (Grant Nos. R43CA221490, R01CA200399, R01CA195503, R01CA216855 and R33CA24018).
Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2021/5
Y1 - 2021/5
N2 - Background: En bloc spondylectomy is the gold standard for surgical resection of sacral chordomas (CHO), but the effect of extent of resection on recurrence and survival in patients with CHO of the cervical spine remains elusive. Methods: MEDLINE, Embase, Scopus, and Cochrane were systematically reviewed. Patients with cervical CHO treated at three tertiary-care academic institutions were reviewed for inclusion. We performed an individual participant data meta-analysis to assess the overall survival (OS) and progression free survival (PFS) after en bloc-gross total resection (GTR) and intralesional-GTR compared to subtotal resection (STR). We then performed an intention-to-treat analysis including all patients with attempted en bloc resection in the en bloc group, regardless of the surgical margins. Results: There was a total of 13 series including 161 patients with cervical CHO, including our current series of 22 patients. GTR (en bloc-GTR + intralesional-GTR) was associated with a significant decrease in the risk of local progression (pooled hazard ratio (PHR) = 0.22; 95% CI 0.08–0.59; p = 0.003) and risk of death (PHR 0.31; 95%; CI 0.12–0.83; p = 0.020). A meta-regression analyses determined that intralesional-GTR improved PFS (PHR 0.35; 95% CI 0.16–0.76; p = 0.009) as well as OS (PHR 0.25; 95% CI 0.08–0.79; p = 0.019) when compared to STR. En bloc-GTR was associated with a significant reduction in the risk of local progression (PHR 0.06; 95% CI 0.01–0.77; p = 0.030), but not a decreased OS (PHR 0.50; 95% CI 0.19–1.27; p = 0.145). Our intention-to-treat analyses revealed a near significant improvement in OS for the en bloc group (PHR: 0.15; 95% CI 0.02–1.22; p = 0.054), and nearly identical improvement in PFS. Radiation data was not available for the studies included in the meta-analysis. Conclusion: This is the first and only meta-analysis of patients with cervical CHO. We found that both en bloc-GTR and intralesional-GTR resulted in improved local tumor control when compared to STR.
AB - Background: En bloc spondylectomy is the gold standard for surgical resection of sacral chordomas (CHO), but the effect of extent of resection on recurrence and survival in patients with CHO of the cervical spine remains elusive. Methods: MEDLINE, Embase, Scopus, and Cochrane were systematically reviewed. Patients with cervical CHO treated at three tertiary-care academic institutions were reviewed for inclusion. We performed an individual participant data meta-analysis to assess the overall survival (OS) and progression free survival (PFS) after en bloc-gross total resection (GTR) and intralesional-GTR compared to subtotal resection (STR). We then performed an intention-to-treat analysis including all patients with attempted en bloc resection in the en bloc group, regardless of the surgical margins. Results: There was a total of 13 series including 161 patients with cervical CHO, including our current series of 22 patients. GTR (en bloc-GTR + intralesional-GTR) was associated with a significant decrease in the risk of local progression (pooled hazard ratio (PHR) = 0.22; 95% CI 0.08–0.59; p = 0.003) and risk of death (PHR 0.31; 95%; CI 0.12–0.83; p = 0.020). A meta-regression analyses determined that intralesional-GTR improved PFS (PHR 0.35; 95% CI 0.16–0.76; p = 0.009) as well as OS (PHR 0.25; 95% CI 0.08–0.79; p = 0.019) when compared to STR. En bloc-GTR was associated with a significant reduction in the risk of local progression (PHR 0.06; 95% CI 0.01–0.77; p = 0.030), but not a decreased OS (PHR 0.50; 95% CI 0.19–1.27; p = 0.145). Our intention-to-treat analyses revealed a near significant improvement in OS for the en bloc group (PHR: 0.15; 95% CI 0.02–1.22; p = 0.054), and nearly identical improvement in PFS. Radiation data was not available for the studies included in the meta-analysis. Conclusion: This is the first and only meta-analysis of patients with cervical CHO. We found that both en bloc-GTR and intralesional-GTR resulted in improved local tumor control when compared to STR.
KW - Cervical spine
KW - Chordoma
KW - En bloc spondylectomy
KW - Gross total resection
KW - Subtotal resection
UR - http://www.scopus.com/inward/record.url?scp=85103674719&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85103674719&partnerID=8YFLogxK
U2 - 10.1007/s11060-021-03742-6
DO - 10.1007/s11060-021-03742-6
M3 - Article
C2 - 33811630
AN - SCOPUS:85103674719
SN - 0167-594X
VL - 153
SP - 65
EP - 77
JO - Journal of neuro-oncology
JF - Journal of neuro-oncology
IS - 1
ER -